Last reviewed · How we verify
Oral Phosphate Supplement
At a glance
| Generic name | Oral Phosphate Supplement |
|---|---|
| Also known as | vitamens, calcium carbonate, calcium citrate, Placebo, latte |
| Sponsor | Kyowa Kirin, Inc. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies. (PHASE2)
- Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Iraqi Patients With Type 2 Diabetes (NA)
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma (PHASE2, PHASE3)
- A Study to Assess Efficacy of Supporting Properties and Safety of ARTNEO in Patients With Knee Osteoarthritis (NA)
- Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones (PHASE4)
- Efficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With XLH (PHASE3)
- Effect of Chewing a Calcium Supplement Before Fluoride Rinse on Salivary Fluoride (EARLY_PHASE1)
- The Effect of Preoperative Oral Dexamethasone Supplementation on the Outcome of Thyroidectomised Patients. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |